Evidence map›Paper›PMID 36456007›Full record

ArticleBMJ open2022

ULTrasound-guided TRAnsfemoral puncture in COmplex Large bORe PCI: study protocol of the UltraCOLOR trial.

Thomas A Meijers, Alexander Nap, Adel Aminian, Joseph Dens, Koen Teeuwen, Jan-Peter van Kuijk, Marleen van Wely, Thomas Schmitz, Yoann Bataille, Adriaan O Kraaijeveld and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03846752 (Complex Large-bore Radial PCI Trial Randomized Trial Reducing Access Site Complications With Slender Technology for Complex PCI), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03846752 nacompletednot on this map

Complex Large-bore Radial PCI Trial Randomized Trial Reducing Access Site Complications With Slender Technology for Complex PCI

TypeinterventionalSponsorMaatschap Cardiologie ZwolleRan2019 to 2020Enrolled388ConditionsComplex Coronary LesionsArmsradial artery access for complex PCI, femoral artery access for complex PCI
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Ultrasound-guided versus fluoroscopy-guided large-bore femoral access in PCI of complex coronary lesions: the international, multicentre, randomised ULTRACOLOR Trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Same-day discharge after large-bore access in percutaneous coronary intervention of chronic total coronary occlusions.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  8. Ultrasound is not the panacea for transfemoral access complications.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Thomas A MeijersDepartment of Cardiology, Isala Heart Centre, Zwolle, The Netherlands.ORCID 0000-0002-4298-1607
Alexander NapDepartment of Cardiology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.
Adel AminianDepartment of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.
Joseph DensDepartment of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Koen TeeuwenDepartment of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.
Jan-Peter van KuijkDepartment of Cardiology, Sint Antonius Hospital, Nieuwegein, The Netherlands.
Marleen van WelyDepartment of Cardiology, Radboudumc, Nijmegen, The Netherlands.
Thomas SchmitzDepartment of Cardiology, Elisabeth-Krankenhaus-Essen GmbH, Essen, Germany.
Yoann BatailleDepartment of Cardiology, Jessa Ziekenhuis vwz, Hasselt, Belgium.
Adriaan O KraaijeveldDepartment of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Vincent RoolvinkDepartment of Cardiology, Isala Heart Centre, Zwolle, The Netherlands.
Renicus S HermanidesDepartment of Cardiology, Isala Heart Centre, Zwolle, The Netherlands.
Thijs L BraberDepartment of Cardiology, Isala Heart Centre, Zwolle, The Netherlands.
Niels van RoyenDepartment of Cardiology, Radboudumc, Nijmegen, The Netherlands.
Maarten A H van LeeuwenDepartment of Cardiology, Isala Heart Centre, Zwolle, The Netherlands m.a.h.van.leeuwen@isala.nl.ORCID 0000-0002-4264-4280
Isala · NLRadboud University Nijmegen · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLElisabeth-Krankenhaus Essen · DEGrand Charleroi Hospital · BEJessa Hospital · BESt. Antonius Ziekenhuis · NLUniversity Medical Center Utrecht · NLZiekenhuis Oost-Limburg · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough recently published evidence favours transradial access (TRA) when using large-bore guiding catheters for percutaneous coronary intervention (PCI) of complex coronary lesions, the femoral artery will still be used in a considerate proportion of patients undergoing complex PCI, especially in PCI of chronic total occlusions (CTO). Ultrasound-guided puncture of the femoral artery may reduce clinically relevant access site complications, but robust evidence is lacking up to date. METHODS AND ANALYSIS: A total of 542 patients undergoing complex PCI, defined as PCI of CTO, complex bifurcation, heavy calcified lesion or left main, in which the 7-F or 8-F transfemoral access is required, will be randomised to ultrasound-guided puncture or fluoroscopy-guided puncture. The primary outcome is the incidence of the composite end-point of clinically relevant access site related bleeding and/or vascular complications requiring intervention. Access site complications and major adverse cardiovascular events up to 1 month will also be compared between both groups. ETHICS AND DISSEMINATION: Ethical approval for the study was granted by the local Ethics Committee ('Medisch Ethische Toetsing Commissie Isala Zwolle') for all Dutch sites, 'Comité Medische Ethiek Ziekenhuis Oost-Limburg' for Hospital Oost-Limburg, 'Comité d'éthique CHU-Charleroi-ISPPC' for Centre Hospilatier Universitaire de Charleroi and 'Ethik Kommission de Ärztekammer Nordrhein' for Elisabeth-Krankenhaus). The trial outcomes will be published in peer-reviewed journals of the concerned literature. The REGISTRATION DETAILS: ClinicalTrials.gov identifier: NCT03846752.

Indexed as

Percutaneous Coronary InterventionVascular DiseasesCyclohexanesFemoral ArteryHumansPuncturesUltrasonography, InterventionalCyclohexanesOmiteCoronary heart diseaseCoronary interventionIschaemic heart disease

Identifiers

PMID36456007
PMCPMC9716808
OpenAlexW4310497563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.